167 related articles for article (PubMed ID: 36986672)
1. The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
Park YS; Kang SB; Marchelletta RR; Penrose HM; Ruiter-Visser R; Jung B; Docherty MJ; Boland BS; Sandborn WJ; McCole DF
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986672
[TBL] [Abstract][Full Text] [Related]
2. A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa.
Kang SB; Marchelletta RR; Penrose H; Docherty MJ; McCole DF
Pharmacol Res Perspect; 2015 Mar; 3(2):e00128. PubMed ID: 26038704
[TBL] [Abstract][Full Text] [Related]
3. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.
Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162
[TBL] [Abstract][Full Text] [Related]
4. Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.
Zong Y; Zhu S; Zhang S; Zheng G; Wiley JW; Hong S
Neurogastroenterol Motil; 2019 Feb; 31(2):e13477. PubMed ID: 30284340
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.
Jin Y; Pridgen TA; Blikslager AT
Inflamm Bowel Dis; 2015 Dec; 21(12):2747-57. PubMed ID: 26332307
[TBL] [Abstract][Full Text] [Related]
6. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.
Cuppoletti J; Blikslager AT; Chakrabarti J; Nighot PK; Malinowska DH
BMC Pharmacol; 2012 May; 12():3. PubMed ID: 22553939
[TBL] [Abstract][Full Text] [Related]
8. Increase in the tight junction protein claudin-1 in intestinal inflammation.
Poritz LS; Harris LR; Kelly AA; Koltun WA
Dig Dis Sci; 2011 Oct; 56(10):2802-9. PubMed ID: 21748286
[TBL] [Abstract][Full Text] [Related]
9. Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective.
Das P; Goswami P; Das TK; Nag T; Sreenivas V; Ahuja V; Panda SK; Gupta SD; Makharia GK
Virchows Arch; 2012 Mar; 460(3):261-70. PubMed ID: 22297703
[TBL] [Abstract][Full Text] [Related]
10. Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function.
Nishii N; Oshima T; Li M; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Miwa H
Pharmacology; 2020; 105(1-2):102-108. PubMed ID: 31536982
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.
Moeser AJ; Nighot PK; Roerig B; Ueno R; Blikslager AT
World J Gastroenterol; 2008 Oct; 14(39):6012-7. PubMed ID: 18932279
[TBL] [Abstract][Full Text] [Related]
12. Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis.
Hu JE; Weiß F; Bojarski C; Branchi F; Schulzke JD; Fromm M; Krug SM
BMC Gastroenterol; 2021 Mar; 21(1):141. PubMed ID: 33789594
[TBL] [Abstract][Full Text] [Related]
13. Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
Arakawa K; Ishigami T; Nakai-Sugiyama M; Chen L; Doi H; Kino T; Minegishi S; Saigoh-Teranaka S; Sasaki-Nakashima R; Hibi K; Kimura K; Tamura K
PLoS One; 2019; 14(6):e0218096. PubMed ID: 31206525
[TBL] [Abstract][Full Text] [Related]
14. Human antigen R (HuR) and Cold inducible RNA-binding protein (CIRP) influence intestinal mucosal barrier function in ulcerative colitis by competitive regulation on Claudin1.
Xu Y; Tian Y; Wang Y; Yang J; Li F; Wan X; Ouyang M
Biofactors; 2021 May; 47(3):427-443. PubMed ID: 33638934
[TBL] [Abstract][Full Text] [Related]
15. Lubiprostone: RU 0211, SPI 0211.
Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
[TBL] [Abstract][Full Text] [Related]
16. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.
Nighot P; Young K; Nighot M; Rawat M; Sung EJ; Maharshak N; Plevy SE; Ma T; Blikslager A
Inflamm Bowel Dis; 2013 Dec; 19(13):2867-77. PubMed ID: 24030525
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
18. Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies.
Raj V; Venkataraman B; Ojha SK; Almarzooqi S; Subramanian VS; Al-Ramadi BK; Adrian TE; Subramanya SB
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049744
[TBL] [Abstract][Full Text] [Related]
19. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
[TBL] [Abstract][Full Text] [Related]
20. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
